![Roger Gomis Cabré](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Roger Gomis Cabré first degree
Entity | Entity type | Industry | |
---|---|---|---|
University of Barcelona
22
| College/University | Other Consumer Services | 22 |
Inbiomotion SL
![]() Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain.
8
| Holding Company | Medical Specialties | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roger Gomis Cabré via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Caixa Capital Risc SGEIC SA
![]() Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor | |
Palau Pharma SA
![]() Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Minoryx Therapeutics SL
![]() Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Medlumics SL
![]() Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Universidad Complutense de Madrid | College/University | Graduate Degree Doctorate Degree | |
ASPY GLOBAL SERVICES, S.A. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree Graduate Degree | |
Aelix Therapeutics SL
![]() Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Ramon Llull University | College/University | Undergraduate Degree Graduate Degree | |
Noucor Health SA
![]() Noucor Health SA Miscellaneous Commercial ServicesCommercial Services J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
ORYZON GENOMICS S.A. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Universidad de Buenos Aires | College/University | Graduate Degree Doctorate Degree | |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
AB-BIOTICS, S.A. | Pharmaceuticals: Other | Director/Board Member Chief Tech/Sci/R&D Officer | |
SpliceBio SL
![]() SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Ysios Capital Partners SGEIC SA
![]() Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Founder Private Equity Investor | |
Ona Therapeutics SL
![]() Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rainier Therapeutics, Inc.
![]() Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Jewish Hospital
![]() Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
Bipi Mobility SL
![]() Bipi Mobility SL Packaged SoftwareTechnology Services Bipi Mobility SL develops applications and provides car rental services. Its services include valet parking at airports and train stations. The company was founded by Peter Christ Hans Joachim Rudolf and is headquartered in Madrid, Spain. | Packaged Software | Director/Board Member | |
Bbbl Practice Slp | Founder | ||
PaulCamper GmbH
![]() PaulCamper GmbH Finance/Rental/LeasingFinance PaulCamper GmbH operates as a holding company, which engages in the operation of a camper sharing platform. It provides campervans and motorhomes rental services. The company was founded by Dirk Fehse and Franziska Schulz in January 2013 and is headquartered in Berlin, Germany. | Finance/Rental/Leasing | Director/Board Member | |
SLL Automotive Group GmbH
![]() SLL Automotive Group GmbH Packaged SoftwareTechnology Services SLL Automotive Group GmbH engages in the development of software solutions for the automotive trading sector. It offers products such as trade-in price calculator for online assessment of old cars and remarketing app for vehicle appraisal, damage assessment, and auctioning. The company was founded by Johannes Stoffel in 2016 and is headquartered in Munich, Germany. | Packaged Software | Director/Board Member | |
ATRECA, INC. | Biotechnology | Director/Board Member | |
AutoSP GOC SMPC
![]() AutoSP GOC SMPC Specialty StoresRetail Trade Spotawheel is a Greek company that buys and sells used cars in a transparent and stress-free way. Spotawheel is based in Athens, Greece and was founded in 2016 by Nikolaos Tsokanos, Charis Arvanitis, and Kiriakos Agadakos. The company offers reliable used cars with photos, videos, and a warranty of up to 5 years. Customers can calculate their monthly payments and choose a payment plan that suits them. The company minimizes costs and transfers the value to the buyer or seller. Charis Arvanitis has been the CEO since 2016. | Specialty Stores | Director/Board Member | |
Adevinta Ventures AS
![]() Adevinta Ventures AS Investment ManagersFinance Adevinta Ventures AS (Adevinta Ventures) subsidiary of Adevinta ASA is a venture capital firm founded in 2016. The firm is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
Universite Montesquieu - Bordeaux IV | College/University | Undergraduate Degree | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Columbus Venture Partners SGEIC SA
![]() Columbus Venture Partners SGEIC SA Investment ManagersFinance Columbus Venture Partners SGEIC SA (Columbus VP) is an independent Spanish venture capital firm which was founded in 2015 by Javier García Cogorro and Damià Tormo Carulla. The firm headquartered in Madri, Spain. | Investment Managers | Private Equity Investor | |
Accure Therapeutics SL
![]() Accure Therapeutics SL Pharmaceuticals: MajorHealth Technology Accure Therapeutics SL is an R & D pharma Spanish company that focuses on developing innovative medicines to treat patients suffering from central nervous system diseases. Accure Therapeutics is based in Barcelona, ES, and has subsidiaries in Spain. The company's research is centered on neurons that suffer dysfunction and the glial environment that supports them, with the aim of impeding their degeneration and death. The company was founded in 2020 by Laurent Nguyen, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
DeepUll Diagnostics SL
![]() DeepUll Diagnostics SL Engineering & ConstructionIndustrial Services DeepUll Diagnostics SL provides technical engineering and consulting services. The company is based in Barcelona, Spain. The Spanish company was founded in 2019 by Jordi Carrera Fabra and Rafel Bru. Jordi Carrera Fabra has been the CEO since 2019. | Engineering & Construction | Director/Board Member | |
Sagetis Biotech SL
![]() Sagetis Biotech SL BiotechnologyHealth Technology Sagetis Biotech SL designs and develops drug-delivery technologies. Its polymeric-based platforms are designed to address areas such as" delivery through the blood-brain barrier, genetic material transfection, and tissue regeneration. The company was founded by David Horna, Eduard Diviu Terradas and Salvador Borros Gomez on April 14, 2010, and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Altamar Private Equity SGIIC SA /Private Equity/
![]() Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity SGIIC SA (Altamar Private Equity) is a private equity arm of Altamar Capital Partners SL founded in 2004. The firm is headquartered in Spain with additional offices in New York and Santiago de Chile. | Investment Managers | Private Equity Investor | |
ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
MTrap, Inc.
![]() MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY. | Miscellaneous Commercial Services | Director/Board Member | |
STAT-Dx Life SL
![]() STAT-Dx Life SL Medical SpecialtiesHealth Technology STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
The University of Colorado School of Medicine | College/University | Doctorate Degree | |
Computershare Ltd. (United Kingdom)
![]() Computershare Ltd. (United Kingdom) Investment ManagersFinance Part of Computershare Ltd., the British company operates a financial administration company. The company is based in Bristol, UK. The company was founded in 1995. The CEO is Nazir Sarkar. | Investment Managers | Corporate Officer/Principal | |
Sheetgo Europe SL
![]() Sheetgo Europe SL Packaged SoftwareTechnology Services Sheetgo Europe SL is a Spanish company that provides a no-code automation solution to collect, manage, and share data using custom workflows from a spreadsheet. The company is based in Valencia, Spain, and has subsidiaries in Brazil and Germany. The company's goal is to remove information silos within teams and automate business processes. Sheetgo is an all-in-one solution that transforms office tools into custom workflows, saving time and allowing teams to focus on what matters. It was founded by Jonatan Gomes da Silva, Rafael Vidal, Lambert Yannik Rault van der Vaart, and Allen Chad Pittman, with Lambert Yannik Rault van der Vaart serving as CEO since incorporation. | Packaged Software | Director/Board Member | |
Roche Glycart AG
![]() Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
AptaTargets SL
![]() AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Ventos Inmuebles SL | Director/Board Member |
Statistics
International
Spain | 34 |
United States | 9 |
Argentina | 3 |
Germany | 3 |
Greece | 2 |
Sectoral
Health Technology | 25 |
Finance | 9 |
Consumer Services | 7 |
Commercial Services | 5 |
Technology Services | 4 |
Operational
Director/Board Member | 100 |
Corporate Officer/Principal | 30 |
Undergraduate Degree | 18 |
Private Equity Investor | 18 |
Doctorate Degree | 17 |
Most connected contacts
- Stock Market
- Insiders
- Roger Gomis Cabré
- Company connections